Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
4548 On Other Exchanges
Symbol
Exchange
4548 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

seikagaku corp (4548) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SEIKAGAKU CORP (4548)

Related News

No related news articles were found.

seikagaku corp (4548) Related Businessweek News

No Related Businessweek News Found

seikagaku corp (4548) Details

Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan. The company operates through Pharmaceutical and LAL segments. It offers pharmaceuticals and medical devices, such as intra-articular injections for improving joint functions under the brand names of ARTZ, ARTZ Dispo, SUPARTZ, ARTZAL, etc.; an injection medical device for treatment of osteoarthritis pain of the knee under the brand name of Gel-One; OPEGAN branded ophthalmic surgical aids; and MucoUp branded surgical aid for endoscopic mucosal resection. The company also provides bulk products consisting of hyaluronic acid, which is primarily used as a raw material of joint function improving agents, ophthalmic surgical aids, and ophthalmic products; and chondroitin sulfate that is used as a raw material in ophthalmic products comprising eye drops and eyewashes, drinks for nutritional fortifications, etc. In addition, it develops endotoxin-detecting reagents under various brands, including the Pyrochrome, ENDOSPECY, TOXICOLOR, etc. for quality control in the manufacturing process and release test of pharmaceuticals and medical devices, as well as dialysis fluid. Further, Seikagaku Corporation develops and markets oral care products comprising mouthwash under the KINUSUI Spray brand. It also exports its products to various countries. The company was formerly known as K.K. Seikagaku Kenkyusho and changed its name to Seikagaku Corporation in 1962. Seikagaku Corporation was founded in 1947 and is headquartered in Tokyo, Japan.

649 Employees
Last Reported Date: 06/19/15
Founded in 1947

seikagaku corp (4548) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

seikagaku corp (4548) Key Developments

Seikagaku Corp. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2015; Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2015 and Fiscal Year 2015 and Fiscal Year Ending March 31, 2016

Seikagaku Corp. reported consolidated earnings results for the first quarter ended June 30, 2015. For the quarter, the company reported net sales of ¥7,762 million compared to ¥7,577 million, operating income of ¥883 million compared to ¥1,187 million and net income attributable to owners of parent of ¥1,032 million or ¥18.18 per share compared to ¥1,251 million or ¥22.02 per share for the last year. The company provided consolidated earnings guidance for the six months ending September 30, 2015 and fiscal year ending March 31, 2016. For the six months, the company expected net sales of ¥15,750 million, operating income of ¥1,750 million and net income attributable to owners of parent of ¥1,700 million or ¥29.93 per share. For the fiscal year ending March 31, 2016, the company expected net sales of ¥30,650 million, operating income of ¥2,400 million and net income attributable to owners of parent of ¥2,900 million or ¥51.05 per share.

Seikagaku Corp. to Report Q1, 2016 Results on Jul 31, 2015

Seikagaku Corp. announced that they will report Q1, 2016 results at 3:00 PM, Tokyo Standard Time on Jul 31, 2015

Seikagaku Corp., Annual General Meeting, Jun 19, 2015

Seikagaku Corp., Annual General Meeting, Jun 19, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4548:JP ¥1,751.00 JPY +149.00

4548 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Zimmer Biomet Holdings Inc $104.37 USD +0.96
View Industry Companies
 

Industry Analysis

4548

Industry Average

Valuation 4548 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEIKAGAKU CORP, please visit www.seikagaku.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.